SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

Published:2024-01-11 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Roa Camilo C.¹,de Los Reyes Mari Rose A.²,Plennevaux Eric³,Smolenov Igor⁴,Hu Branda⁴,Gao Faith⁴,Ilagan Hannalyn⁴,Ambrosino Donna⁵,Siber George⁶,Clemens Ralf⁷,Han Htay Htay⁴

Affiliation:

1. Department of Physiology, Philippine General Hospital, University of the Philippines, Manila, Philippines

2. Local Clinics, Las Pinas Doctors Hospital, Las Pinas City, Philippines

3. Clinical Development, Clover Biopharmaceuticals, Cambridge, UK

4. Clinical Development, Clover Biopharmaceuticals, Boston, MA, USA

5. Independent Advisor, Stuart, FL, USA

6. Independent Advisor, New York, NY, USA

7. Global Research in Infectious Diseases, Rio de Janeiro, Brazil

Funder

Clover Biopharmaceuticals

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2301632

Reference38 articles.

1. Are COVID surges becoming more predictable? New Omicron variants offer a hint

2. Spike protein of SARS-CoV-2 variants: a brief review and practical implications

3. The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines

4. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants

5. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3